Biopsy Devices | Europe (Supplemental) | 2016 | Market Analysis
The European market for biopsy devices will be primarily driven by wider implementation of national cancer screening programs, an increase in reimbursement coverage for biopsy procedures, increasing adoption of premium-priced devices, and favorable demographics; these factors will result in market growth through 2024.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biopsy devices in Europe across a 10-year period.